Advertisement
UK markets close in 41 minutes
  • FTSE 100

    8,065.12
    +24.74 (+0.31%)
     
  • FTSE 250

    19,599.76
    -119.61 (-0.61%)
     
  • AIM

    752.75
    -1.94 (-0.26%)
     
  • GBP/EUR

    1.1664
    +0.0019 (+0.16%)
     
  • GBP/USD

    1.2505
    +0.0042 (+0.34%)
     
  • Bitcoin GBP

    50,742.90
    -1,258.77 (-2.42%)
     
  • CMC Crypto 200

    1,377.26
    -5.31 (-0.38%)
     
  • S&P 500

    5,001.65
    -69.98 (-1.38%)
     
  • DOW

    37,775.71
    -685.21 (-1.78%)
     
  • CRUDE OIL

    82.30
    -0.51 (-0.62%)
     
  • GOLD FUTURES

    2,354.20
    +15.80 (+0.68%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,879.09
    -209.61 (-1.16%)
     
  • CAC 40

    8,001.43
    -90.43 (-1.12%)
     

Boeing, American Airlines stumble while Cerner jump

Boeing, American Airlines stumble while Cerner jump

NEW YORK (AP) -- Stocks that moved substantially or traded heavily on Tuesday:

Boeing Co., down $5.48 to $369.04

The plane maker's deliveries tumbled in the first quarter after two deadly crashes prompted regulators to ground the 737 Max jet.

American Airlines Group Inc., down 57 cents to $33.31

The airline is cutting a key revenue measure, citing the grounded Boeing 737 Max jets and the lingering impact from the government shutdown.

Wynn Resorts Ltd., down $5.59 to $139.26

The casino operator pulled out of talks to buy Australia's Crown Resorts after that company disclosed negotiation details.

Pentair PLC, down $6.13 to $39.13

ADVERTISEMENT

The maker of water filters and pumps for pools and other systems slashed its profit forecast, citing bad weather.

Avaya Holdings Corp., up 74 cents to $18.49

The communications software maker is preparing to auction the company, according to media reports.

Lindsay Corp., down $8.98 to $85.11

The irrigation equipment maker reported a surprise fiscal second-quarter loss and revenue fell short of forecasts.

Cerner Corp., up $5.88 to $62.97

The health care information technology company added $1.2 billion in stock buybacks after reaching a deal with activist investor Starboard Value L.P.

Zogenix Inc., down $11.89 to $39.96

The Food and Drug Administration rejected one of the drug maker's experimental epilepsy treatments.